BishopNJMorleyRDayJPLucasA. Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med1997;336:1557–61.
2.
BougleDSabatierJPBureauFLarocheD. Relationship between bone mineralization and aluminium in the healthy infant. Eur J Clin Nutr1998;52:431–5.
3.
MorenoADomínguezCBarrosoC. Aluminum and intravenous drugs in the neonate (letter). Ann Pharmacother1993;27:1538–9.
4.
MouserJFWuAHBHersonVC. Aluminum contamination of neonatal parenteral nutrient solutions and additives (letter). Am J Health Syst Pharm1998;55:1071–2.
5.
BaumannL. Glass is the major source of aluminium in parenterals (Glas ist die Aluminium-Kontaminationsquelle für Parenteralia). Krankenhauspharmazie1998;19:71–4.
6.
TrisselLA. Handbook of injectable drugs. Bethesda, MD: American Society of Health-System Pharmacists, 1998:166.
7.
Department of Health and Human Services, Food and Drug Administration.Aluminum in large and small volume parenterals used in total parenteral nutrition: Proposed rule. Fed Regist1998;63:176–85.
8.
KleinGLLeichtnerAMHeymanMB. Aluminum in large and small volume parenterals used in total parenteral nutrition: Response to the Food and Drug Administration notice of proposed rule by the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr1998;27:457–60.
